Medtronic
Medtronic is a global leader in healthcare technology that researches, designs, manufactures, and sells device-based medical therapies and services. The company focuses on alleviating pain and restoring health through biomedical engineering, integrating artificial intelligence and data analytics to personalize patient care. It operates a vast distribution network serving healthcare systems and physicians in more than 150 countries.
Financials
Based on Q3 2026 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metricBusiness Segments
Cardiovascular Portfolio
primaryDevelops and markets products for the diagnosis and treatment of heart rhythm disorders, heart failure, and vascular diseases. This segment includes technologies for cardiac ablation, structural heart repair, and coronary artery interventions.
Micra transcatheter pacing system, Azure MRI SureScan, Evolut FX+ TAVR systems, Onyx Frontier drug-eluting stents, Arctic Front Advanced Cardiac Cryoblation System, Symplicity Spyral Renal Denervation system
Electrophysiologists, Interventional cardiologists, Vascular surgeons, Radiologists
Neuroscience Portfolio
majorProvides integrated therapies for cranial and spinal technologies, specialty therapies for ENT and pelvic health, and neuromodulation systems. It focuses on surgical precision through robotic guidance and AI-driven surgical planning.
StealthStation S8 surgical navigation system, Mazor robotic guidance systems, Infuse Bone Graft, InterStim Micro rechargeable neurostimulators, Percept neurostimulators, SynchroMed III Implantable Infusion System
Spinal surgeons, Neurosurgeons, Neurologists, Pain management specialists, Urologists
Medical Surgical Portfolio
majorFocuses on advanced and general surgical products, including robotic-assisted surgery platforms, patient monitoring, and airway management tools. These products are used across hospitals, ambulatory centers, and alternate site healthcare providers.
Hugo robotic-assisted surgery (RAS) system, Signia powered stapling system, LigaSure vessel sealing instruments, GI Genius intelligent endoscopy module, Nellcor pulse oximetry monitors, McGRATH MAC video laryngoscopes
General surgeons, Anesthesiologists, Healthcare systems, Ambulatory care centers
Diabetes Operating Unit
moderateDevelops and markets advanced insulin delivery systems and continuous glucose monitoring (CGM) technologies for Type 1 and Type 2 diabetes management. The company has announced intentions to separate this business into an independent entity.
MiniMed 780G system, Guardian Connect CGM system, Simplera platform, InPen smart insulin pen
Endocrinologists, Primary care physicians, Diabetic patients
Segment Financials
Cardiovascular — Accelerated amortization
View metricBusiness Overview
Competitive Position
A leading global healthcare technology company characterized by a massive R&D pipeline and a dominant presence in cardiovascular and surgical robotics markets.
Geographies
United States, Western Europe, China, Japan, Ireland
Customer Segments
Hospitals, Physicians, Group Purchasing Organizations (GPOs), Integrated Delivery Networks (IDNs)
Upstream Dependencies
Specialized component manufacturers, Raw material suppliers, Third-party R&D funding partners
Downstream Customers
Hospitals, Ambulatory surgical centers, Long-term care facilities, Home care patients
Competitors & Partners
Competitors
Stryker
SYK
Competitor in spinal and neurosurgical products
Boston Scientific
BSX
Competitor in neuromodulation and cardiovascular devices
Abbott
ABT
Competitor in cardiovascular and diabetes care
Johnson & Johnson
JNJ
Competitor in surgical and orthopedic technologies
Intuitive Surgical
ISRG
Competes in robotic-assisted surgery and traditional MIS instruments.
Becton, Dickinson and Company
BDX
Competitor in interventional and surgical products
Edwards Lifesciences
EW
Primary competitor in TAVR and surgical heart valve markets.
DexCom
DXCM
Competitor in continuous glucose monitoring
Subsidiaries
Mazor Robotics
Robotic guidance systems for spine procedures
Affera
Cardiac mapping and navigation systems
Medtronic FAQ
Common questions about Medtronic
Medtronic is a global leader in healthcare technology that researches, designs, manufactures, and sells device-based medical therapies and services. The company focuses on alleviating pain and restoring health through biomedical engineering, integrating artificial intelligence and data analytics to personalize patient care. It operates a vast distribution network serving healthcare systems and physicians in more than 150 countries.
Medtronic (MDT) has a market capitalization of $100.91B and trades on NYSE.
Medtronic generated $35.5B in trailing twelve-month revenue with net income of $4.6B, representing a net margin of 13.0%. Gross margin stands at 64.9%. These figures are based on the Q1 2026 filing.
Medtronic's key competitors include Stryker Corporation, Boston Scientific, Abbott Laboratories, and others. These companies compete in similar markets and product categories.
Medtronic has approximately 95,000 employees.